Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Non-Current Assets (2016 - 2026)

Rockwell Medical filings provide 16 years of Non-Current Assets readings, the most recent being $19.0 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 14.41% to $19.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $80.9 million, a 12.4% decrease, with the full-year FY2025 number at $19.0 million, down 14.41% from a year prior.
  • Non-Current Assets hit $19.0 million in Q4 2025 for Rockwell Medical, down from $20.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $24.4 million in Q3 2023 to a low of $10.2 million in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $16.1 million (2021), compared with a mean of $16.9 million.
  • Biggest five-year swings in Non-Current Assets: fell 14.76% in 2022 and later skyrocketed 122.84% in 2024.
  • Rockwell Medical's Non-Current Assets stood at $13.3 million in 2021, then fell by 14.76% to $11.3 million in 2022, then surged by 106.65% to $23.4 million in 2023, then dropped by 5.23% to $22.2 million in 2024, then dropped by 14.41% to $19.0 million in 2025.
  • The last three reported values for Non-Current Assets were $19.0 million (Q4 2025), $20.0 million (Q3 2025), and $21.0 million (Q2 2025) per Business Quant data.